FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311537942> ?p ?o ?g. }

• W4311537942 endingPage "102720" @default.
• W4311537942 startingPage "102720" @default.
• W4311537942 abstract "The discovery of new effective and safe antimalarial drugs is mandatory. In this report, we formulate and evaluate transdermal (td) 1,2,6,7-tetraoxaspiro[7.11]nonadecane (N-89) using the Plasmodium berghei rodent malaria parasite in vivo model. The selected solvent for the ointment type of td N-89 was polyethylene glycol (PEG) [PEG400:PEG 4000 = 8:1 (v/w)]. We tested different application areas of 4, 6, and 8 cm2 on the shaved backs of mice. Pharmacokinetic (PK) analysis of N-89 parameters after a single 4 cm2 transdermal application revealed that the Tmax was 2 h, the T1/2 was 1.9 h, and the AUC was 1951.1 ng.h/mL. More than 10 ng/mL of plasma concentration was maintained for 12 h. The ED50 values for the 4, 6, and 8 cm2 application areas in a 4-day suppressive test were 18.9, 25.1, and 26.8 mg/kg, respectively. We additionally tested the cure effect of td N-89 in mice at a dose of 60 mg/kg, twice daily for 4 days at 0.2% parasitemia. Parasites disappeared following day 7 post-treatment in all td N-89 treated groups. Mice were cured without any parasite recurrence or dermal irritation. In conclusion, this study determined for the first time the PK parameters and effect of a new ointment type of td N-89. This suggests that transdermal treatment with N-89 is an effective and safe alternative route for the treatment of malaria, especially in children." @default.
• W4311537942 created "2022-12-27" @default.
• W4311537942 creator A5010373417 @default.
• W4311537942 creator A5019489630 @default.
• W4311537942 creator A5022349679 @default.
• W4311537942 creator A5032092464 @default.
• W4311537942 creator A5044335175 @default.
• W4311537942 creator A5052590858 @default.
• W4311537942 creator A5069278982 @default.
• W4311537942 creator A5077560972 @default.
• W4311537942 date "2023-04-01" @default.
• W4311537942 modified "2023-10-02" @default.
• W4311537942 title "Formulation and evaluation of the antimalarial N-89 as a transdermal drug candidate" @default.
• W4311537942 cites W1744912403 @default.
• W4311537942 cites W1889204973 @default.
• W4311537942 cites W1972693841 @default.
• W4311537942 cites W1990524106 @default.
• W4311537942 cites W1999124243 @default.
• W4311537942 cites W2008079850 @default.
• W4311537942 cites W2009957165 @default.
• W4311537942 cites W2016181184 @default.
• W4311537942 cites W2080430067 @default.
• W4311537942 cites W2113115497 @default.
• W4311537942 cites W2121739845 @default.
• W4311537942 cites W2261160844 @default.
• W4311537942 cites W2557724747 @default.
• W4311537942 cites W2955276803 @default.
• W4311537942 cites W3087429957 @default.
• W4311537942 cites W3108763233 @default.
• W4311537942 cites W3161427380 @default.
• W4311537942 cites W3200795352 @default.
• W4311537942 cites W4293049708 @default.
• W4311537942 doi "https://doi.org/10.1016/j.parint.2022.102720" @default.
• W4311537942 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36516945" @default.
• W4311537942 hasPublicationYear "2023" @default.
• W4311537942 type Work @default.
• W4311537942 citedByCount "2" @default.
• W4311537942 countsByYear W43115379422023 @default.
• W4311537942 crossrefType "journal-article" @default.
• W4311537942 hasAuthorship W4311537942A5010373417 @default.
• W4311537942 hasAuthorship W4311537942A5019489630 @default.
• W4311537942 hasAuthorship W4311537942A5022349679 @default.
• W4311537942 hasAuthorship W4311537942A5032092464 @default.
• W4311537942 hasAuthorship W4311537942A5044335175 @default.
• W4311537942 hasAuthorship W4311537942A5052590858 @default.
• W4311537942 hasAuthorship W4311537942A5069278982 @default.
• W4311537942 hasAuthorship W4311537942A5077560972 @default.
• W4311537942 hasConcept C10138342 @default.
• W4311537942 hasConcept C112705442 @default.
• W4311537942 hasConcept C150903083 @default.
• W4311537942 hasConcept C162324750 @default.
• W4311537942 hasConcept C185592680 @default.
• W4311537942 hasConcept C202751555 @default.
• W4311537942 hasConcept C203014093 @default.
• W4311537942 hasConcept C205679159 @default.
• W4311537942 hasConcept C207001950 @default.
• W4311537942 hasConcept C2775867548 @default.
• W4311537942 hasConcept C2776964284 @default.
• W4311537942 hasConcept C2777063393 @default.
• W4311537942 hasConcept C2777237215 @default.
• W4311537942 hasConcept C2778048844 @default.
• W4311537942 hasConcept C2778371730 @default.
• W4311537942 hasConcept C42533223 @default.
• W4311537942 hasConcept C54400483 @default.
• W4311537942 hasConcept C55493867 @default.
• W4311537942 hasConcept C71924100 @default.
• W4311537942 hasConcept C86803240 @default.
• W4311537942 hasConcept C98274493 @default.
• W4311537942 hasConceptScore W4311537942C10138342 @default.
• W4311537942 hasConceptScore W4311537942C112705442 @default.
• W4311537942 hasConceptScore W4311537942C150903083 @default.
• W4311537942 hasConceptScore W4311537942C162324750 @default.
• W4311537942 hasConceptScore W4311537942C185592680 @default.
• W4311537942 hasConceptScore W4311537942C202751555 @default.
• W4311537942 hasConceptScore W4311537942C203014093 @default.
• W4311537942 hasConceptScore W4311537942C205679159 @default.
• W4311537942 hasConceptScore W4311537942C207001950 @default.
• W4311537942 hasConceptScore W4311537942C2775867548 @default.
• W4311537942 hasConceptScore W4311537942C2776964284 @default.
• W4311537942 hasConceptScore W4311537942C2777063393 @default.
• W4311537942 hasConceptScore W4311537942C2777237215 @default.
• W4311537942 hasConceptScore W4311537942C2778048844 @default.
• W4311537942 hasConceptScore W4311537942C2778371730 @default.
• W4311537942 hasConceptScore W4311537942C42533223 @default.
• W4311537942 hasConceptScore W4311537942C54400483 @default.
• W4311537942 hasConceptScore W4311537942C55493867 @default.
• W4311537942 hasConceptScore W4311537942C71924100 @default.
• W4311537942 hasConceptScore W4311537942C86803240 @default.
• W4311537942 hasConceptScore W4311537942C98274493 @default.
• W4311537942 hasFunder F4320320912 @default.
• W4311537942 hasLocation W43115379421 @default.
• W4311537942 hasLocation W43115379422 @default.
• W4311537942 hasOpenAccess W4311537942 @default.
• W4311537942 hasPrimaryLocation W43115379421 @default.
• W4311537942 hasRelatedWork W1992682676 @default.
• W4311537942 hasRelatedWork W2002651169 @default.
• W4311537942 hasRelatedWork W2024884191 @default.
• W4311537942 hasRelatedWork W2107494070 @default.

• next